| Aktsiad | 585,248 B | — | KO KoAct | 0 | Tervishoiu | | 3.8.2023 | 21 596,8 | 8,05 | 37,04 |
KO | Aktsiad | 286,374 B | — | KO KODEX | 0,45 | Tervishoiu | FnGuide Bio Index - Benchmark TR Gross | 13.5.2016 | 11 865,53 | 5,44 | 37,93 |
TE | Aktsiad | 265,194 B | — | TE Tiger ETF | 0,4 | Tervishoiu | KRX Bio K-New Deal Index - KRW - Benchmark TR Gross | 6.10.2020 | 8021,07 | 6,03 | 51,44 |
TE | Aktsiad | 189,277 B | — | TE Tiger ETF | 0,4 | Tervishoiu | KRX Healthcare - KRW | 15.7.2011 | 46 695,71 | 4,63 | 39,62 |
TE | Aktsiad | 97,468 B | — | TE Tiger ETF | 0,3 | Tervishoiu | NASDAQ / Biotechnology | 26.8.2014 | 31 635,63 | 4,88 | 21,01 |
KO | Aktsiad | 94,881 B | — | KO KODEX | 0,09 | Tervishoiu | KRX Healthcare - KRW | 28.3.2017 | 21 243,97 | 4,63 | 39,65 |
TE | Aktsiad | 74,278 B | — | TE Tiger ETF | 0,4 | Tervishoiu | KOSDAQ 150 Biotech Index - KRW - Benchmark TR Gross | 14.12.2016 | 18 235,61 | 10,44 | 59,1 |
| Aktsiad | 71,702 B | — | KR KB RISE | 0 | Tervishoiu | KRX Bio Top 10 Index - KRW - Benchmark TR Gross | 24.12.2024 | 15 679,68 | 9,56 | 68,04 |
TE | Aktsiad | 64,212 B | — | TE Tiger ETF | 0,49 | Tervishoiu | Solactive China Biotech Index | 3.12.2020 | 8968,25 | 4,03 | 28,69 |
KO | Aktsiad | 61,401 B | — | KO KODEX | 0,25 | Tervishoiu | S&P Health Care Select Sector | 21.3.2023 | 13 619,17 | 4,86 | 22,5 |
TE | Aktsiad | 44,498 B | — | TE Tiger ETF | 0,45 | Tervishoiu | Indxx Global Obesity Treatment Top 2 Plus index - KRW - Benchmark Price Return | 29.2.2024 | 10 059,99 | 7,96 | 17,83 |
KO | Aktsiad | 42,664 B | — | KO KODEX | 0,45 | Tervishoiu | iSelect Global Obesity Treatment TOP2 Plus Index - KRW - Benchmark TR Net | 14.2.2024 | 10 794,98 | 5,08 | 12,43 |
SP | Aktsiad | 38,413 B | 15,229 M | SP SPDR | 0,08 | Tervishoiu | S&P Health Care Select Sector | 16.12.1998 | 143,29 | 4,86 | 22,63 |
TE | Aktsiad | 31,309 B | — | TE Tiger ETF | 0 | Tervishoiu | S&P Global 1200 Health Care Custom Index - krw - Benchmark TR Gross | 29.6.2016 | 25 608,61 | 0 | 0 |
TE | Aktsiad | 31,058 B | — | TE Tiger ETF | 0,4 | Tervishoiu | KOSPI 200 Health Care Index - KRW | 23.9.2015 | 20 822,89 | 2,91 | 30,55 |
| Aktsiad | 28,453 B | — | HW Hwabao | 0,6 | Tervishoiu | CSI Medical Index Yield - Benchmark TR Gross | 20.5.2019 | 0,34 | 3,08 | 30,88 |
KO | Aktsiad | 21,423 B | — | KO KODEX | 0,25 | Tervishoiu | S&P Biotechnology Select Industry | 31.10.2013 | 41 813,56 | 0 | 0 |
EF | Aktsiad | 17,417 B | — | EF E Fund | 0 | Tervishoiu | CSI 300 Medical and Health Index - CNY - Benchmark TR Gross | 9.1.2021 | 0,37 | 3,4 | 26,67 |
VA | Aktsiad | 16,498 B | 231 887,9 | VA Vanguard | 0,09 | Tervishoiu | MSCI US IMI 25/50 Health Care | 26.1.2004 | 272,55 | 5,01 | 23,09 |
NH | Aktsiad | 15,996 B | — | NH NH-Amundi | 0 | Tervishoiu | | 26.11.2024 | 14 892,57 | 5 | 44,18 |
| Aktsiad | 14,213 B | — | KO KoAct | 0,5 | Tervishoiu | | 11.11.2025 | 10 338,06 | 5,59 | 22,65 |
| Aktsiad | 12,596 B | — | KR KB RISE | 0 | Tervishoiu | FnGuide HealthCare Index - KRW - Benchmark TR Net | 23.9.2016 | 16 773,64 | 4,73 | 37,18 |
| Aktsiad | 9,163 B | — | AC ACE | 0,3 | Tervishoiu | Solactive Global Big Pharma Index - Benchmark Price Return | 19.11.2024 | 12 860,55 | 7,21 | 21,79 |
KI | Aktsiad | 8,411 B | — | KI Kiwoom | 0,49 | Tervishoiu | FnGuide Medical AI Index - KRW - Benchmark TR Gross | 28.5.2024 | 12 779,55 | 0 | 0 |
IS | Aktsiad | 8,227 B | 1,762 M | IS iShares | 0,44 | Tervishoiu | NYSE Biotechnology (TR) | 5.2.2001 | 169,45 | 5,1 | 21,9 |
| Aktsiad | 8,18 B | — | AC ACE | 0,45 | Tervishoiu | Solactive Eli Lilly Value Chain Index - Benchmark Price Return | 19.11.2024 | 12 381,65 | 3,6 | 21,75 |
| Aktsiad | 7,941 B | — | KO KoAct | 0 | Tervishoiu | | 27.1.2026 | 10 133,67 | 4,34 | 29,64 |
SP | Aktsiad | 7,494 B | 9,357 M | SP SPDR | 0,35 | Tervishoiu | S&P Biotechnology Select Industry | 31.1.2006 | 119,59 | 5,08 | 0 |
| Aktsiad | 6,848 B | — | KO KoAct | 0,5 | Tervishoiu | | 3.9.2024 | 12 841,88 | 4,21 | 17,95 |
BO | Aktsiad | 6,662 B | — | BO Bosera | 0,65 | Tervishoiu | Hang Seng Healthcare Index - CNY - Benchmark TR Gross | 18.3.2021 | 0,61 | 2,75 | 12,8 |
CH | Aktsiad | 6,371 B | — | CH ChinaAMC | 0,65 | Tervishoiu | Hang Seng Biotech Index - HKD - Benchmark TR Net | 29.9.2021 | 0,82 | 3 | 21,32 |
TE | Aktsiad | 6,279 B | — | TE Tiger ETF | 0,5 | Tervishoiu | FnGuide Medical Device Index - KRX - Benchmark TR Net | 7.11.2018 | 17 612,46 | 2,77 | 23,45 |
KI | Aktsiad | 5,925 B | — | KI Kiwoom | 0,49 | Tervishoiu | Solactive Blockbuster Biotech Drugs Index - CNY - Benchmark TR Net | 28.5.2024 | 11 652,44 | 4,37 | 17,87 |
| Aktsiad | 5,693 B | — | MA Maxwealth | 0,6 | Tervishoiu | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 22.4.2021 | 0,49 | 2,64 | 31,06 |
| Aktsiad | 5,441 B | — | NI Nippon | 0,19 | Tervishoiu | Nifty Pharma Index - INR - Benchmark TR Gross | 2.7.2021 | 17,49 | 4,59 | 31,47 |
NF | Aktsiad | 5,437 B | — | NF NEXT FUNDS | 0,32 | Tervishoiu | | 21.3.2008 | 33 088,93 | 1,86 | 21,64 |
| Aktsiad | 5,154 B | — | KR KB RISE | 0,35 | Tervishoiu | KEDI Global Obesity Care Industry Top2+ Index - KRW - Benchmark TR Net | 27.2.2024 | 9602,93 | 7,72 | 19,09 |
TE | Aktsiad | 4,915 B | — | TE Tiger ETF | 0,4 | Tervishoiu | TOPIX-17 PHARMACEUTICAL - JPY | 29.6.2016 | 12 065 | 0 | 0 |
IN | Aktsiad | 4,859 B | — | IN Invesco | 0 | Tervishoiu | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 16.10.2024 | 1,69 | 3,45 | 24,62 |
IC | Aktsiad | 4,738 B | — | IC ICBC | 0 | Tervishoiu | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 26.3.2025 | 1,24 | 0 | 0 |
EF | Aktsiad | 4,018 B | — | EF E Fund | 0 | Tervishoiu | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 18.3.2025 | 1,18 | 0 | 0 |
GU | Aktsiad | 3,732 B | — | GU Guotai | 0,6 | Tervishoiu | CSI Biomedical Index - CNY - Benchmark TR Gross | 18.4.2019 | 1 | 0 | 0 |
IS | Aktsiad | 3,642 B | 227 363,2 | IS iShares | 0,4 | Tervishoiu | S&P Global 1200 Health Care Sector Capped Index - USD - Benchmark TR Net | 13.11.2001 | 93,91 | 4,19 | 21,81 |
XT | Aktsiad | 3,236 B | — | XT Xtrackers | 0,25 | Tervishoiu | MSCI World Index / Health Care -SEC | 22.11.2010 | 55,43 | 4,44 | 21,81 |
IS | Aktsiad | 3,221 B | 2,437 M | IS iShares | 0,38 | Tervishoiu | DJ US Select / Medical Equipment | 1.5.2006 | 53,23 | 3,79 | 29,41 |
FU | Aktsiad | 3,148 B | — | FU Fullgoal | 0,6 | Tervishoiu | Hang Seng Hong Kong Stock Connect Healthcare Index - CNY - Chinese Renminbi - Benchmark TR Gross | 14.6.2023 | 1,44 | 0 | 0 |
IS | Aktsiad | 2,906 B | 903 150,2 | IS iShares | 0,38 | Tervishoiu | Russell 1000 Health Care RIC 22.5/45 Capped Index | 12.6.2000 | 61,66 | 4,86 | 22,76 |
FI | Aktsiad | 2,823 B | 189 727,8 | FI Fidelity | 0,08 | Tervishoiu | MSCI US IMI 25/50 Health Care | 21.10.2013 | 70,53 | 4,77 | 22,64 |
NH | Aktsiad | 2,735 B | — | NH NH-Amundi | 0,45 | Tervishoiu | iSelect K-MediTech Index - KRW - Benchmark Price Return | 21.12.2023 | 9115,65 | 3,43 | 26,31 |
IS | Aktsiad | 2,548 B | — | IS iShares | 0,15 | Tervishoiu | S&P 500 CAPPED 35/20 HEALTH CARE NTR | 20.11.2015 | 11,8 | 4,86 | 22,63 |
| Aktsiad | 2,455 B | — | HW Hwabao | 0 | Tervishoiu | Hang Seng SCHK Innovative Drug Select Index - HKD - Benchmark TR Gross | — | 4,49 B | 0 | 0 |
GU | Aktsiad | 2,304 B | — | GU Guotai | 0,6 | Tervishoiu | CSI Medical Index Yield - Benchmark TR Gross | 24.12.2020 | 0,42 | 3,08 | 30,9 |
FT | Aktsiad | 2,289 B | 62 733,24 | FT First Trust | 0,54 | Tervishoiu | NYSE Arca Biotechnology Index | 19.6.2006 | 202,01 | 3,45 | 22,71 |
CH | Aktsiad | 2,209 B | — | CH ChinaAMC | 0,75 | Tervishoiu | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 15,76 | 3,09 | 22,35 |
CH | Aktsiad | 2,209 B | — | CH ChinaAMC | 0,75 | Tervishoiu | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 15,76 | 3,09 | 22,35 |
PA | Aktsiad | 1,819 B | — | PA Ping An | 0,6 | Tervishoiu | CSI Pharmaceutical and Medical Device Innovation Index - CNY - Benchmark TR Gross | 9.6.2021 | 0,36 | 4,13 | 25,07 |
EF | Aktsiad | 1,618 B | — | EF E Fund | 0,2 | Tervishoiu | Yield of China Securities Hong Kong Stock Connect Medical and Health Composite Index - CNY - Benchmark TR Net | 19.1.2022 | 1,11 | 2,5 | 20,25 |
HE | Aktsiad | 1,614 B | — | HE Harvest ETFs | 1,06 | Tervishoiu | | 19.11.2014 | 7,11 | 5,01 | 23,83 |
AM | Aktsiad | 1,49 B | — | AM Amundi | 0,5 | Tervishoiu | MSCI World IMI Virology Select Index - KRW - Benchmark TR Net | 8.6.2022 | 9937,75 | 2,82 | 14,76 |
EF | Aktsiad | 1,448 B | — | EF E Fund | 0,2 | Tervishoiu | China Securities Medical Index - CNY - Benchmark TR Gross | 8.7.2021 | 0,4 | 4,4 | 29,55 |
EF | Aktsiad | 1,435 B | — | EF E Fund | 0,2 | Tervishoiu | CSI Biotechnology Theme Index - CNY - Benchmark TR Gross | 14.1.2021 | 0,5 | 2,8 | 29,2 |
IS | Aktsiad | 1,417 B | — | IS iShares | 0,18 | Tervishoiu | MSCI Europe Health Care 20/35 Capped Index - EUR | 17.11.2020 | 7,11 | 3,73 | 19,22 |
CA | Aktsiad | 1,391 B | — | CA Cathay | 1,05 | Tervishoiu | Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net | 22.11.2021 | 8,22 | 3,39 | 17,66 |
IS | Aktsiad | 1,361 B | — | IS iShares | 0,46 | Tervishoiu | S&P Global 1200 Healthcare Sector Index - AUD | 13.11.2001 | 135,07 | 0 | 0 |
EF | Aktsiad | 1,323 B | — | EF E Fund | 0,2 | Tervishoiu | CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross | 3.2.2021 | 0,68 | 3,14 | 28,62 |
GU | Aktsiad | 1,314 B | — | GU Guotai | 0,6 | Tervishoiu | SSE STAR Market Innovative Drug Index - CNY - Benchmark TR Gross | 1.8.2025 | 0,95 | 0 | 0 |
HA | Aktsiad | 1,129 B | — | HA Harvest | 0,6 | Tervishoiu | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 30.7.2025 | 0,91 | 0 | 0 |
XT | Aktsiad | 1,116 B | — | XT Xtrackers | 0,12 | Tervishoiu | MSCI USA / Health Care -SEC | 12.9.2017 | 58,78 | 5,07 | 22,81 |
XT | Aktsiad | 1,116 B | — | XT Xtrackers | 0,12 | Tervishoiu | MSCI USA / Health Care -SEC | 12.9.2017 | 58,78 | 5,07 | 22,81 |
VA | Aktsiad | 1,05 B | 433 579,7 | VA VanEck | 0,36 | Tervishoiu | MVIS US Listed Pharmaceutical 25 | 20.12.2011 | 104,17 | 4,92 | 18,95 |
IS | Aktsiad | 1,008 B | 86 576,5 | IS iShares | 0,38 | Tervishoiu | DJ US Select / Pharmaceutical | 1.5.2006 | 86,97 | 4,59 | 21,41 |
IS | Aktsiad | 1,001 B | — | IS iShares | 0,4 | Tervishoiu | STOXX Global Breakthrough Healthcare (USD)(NR) | 8.9.2016 | 8,73 | 3,82 | 20,92 |
IS | Aktsiad | 1,001 B | — | IS iShares | 0,4 | Tervishoiu | STOXX Global Breakthrough Healthcare (USD)(NR) | 8.9.2016 | 8,73 | 3,82 | 20,92 |
GX | Aktsiad | 977,457 M | — | GX Global X | 0,59 | Tervishoiu | FactSet Japan Bio & Med Technologies Index - JPY - Benchmark TR Net | 21.6.2021 | 1739,46 | 1,9 | 19,17 |
CS | Aktsiad | 926,443 M | — | CS CSOP | 1,5 | Tervishoiu | Hang Seng Biotech Index - HKD - Benchmark TR Net | 21.7.2021 | 3,75 | 3,33 | 23,96 |
| Aktsiad | 897,705 M | — | WA Wanjia | 0 | Tervishoiu | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 13.9.2024 | 1,62 | 3,45 | 24,62 |
IS | Aktsiad | 882,603 M | — | IS iShares | 0,35 | Tervishoiu | NASDAQ / Biotechnology | 19.10.2017 | 8,52 | 0 | 0 |
FT | Aktsiad | 851,151 M | 27 073,22 | FT First Trust | 0,61 | Tervishoiu | StrataQuant Health Care Index | 8.5.2007 | 110,48 | 3,02 | 17,23 |
AM | Aktsiad | 827,261 M | — | AM Amundi | 0,3 | Tervishoiu | STOXX Europe 600 / Health Care (Capped) - SS | 17.1.2019 | 150,86 | 2,85 | 19,76 |
AM | Aktsiad | 827,261 M | — | AM Amundi | 0,3 | Tervishoiu | STOXX Europe 600 / Health Care (Capped) - SS | 17.1.2019 | 150,86 | 2,85 | 19,76 |
| Aktsiad | 742,094 M | 103 248,7 | PB Portfolio Building Block | 0,13 | Tervishoiu | BITA Global Pharma and Biotech Select Index - Benchmark TR Net | 24.11.2025 | 25,55 | 4,93 | 20,32 |
CA | Aktsiad | 721,535 M | — | CA Cathay | 0,41 | Tervishoiu | Bloomberg Barclays 15+ Year Healthcare Select Index - Benchmark TR Net | 23.4.2019 | 30,05 | 0 | 0 |
IS | Aktsiad | 706,186 M | — | IS iShares | 0,46 | Tervishoiu | STOXX Europe 600 / Health Care (Capped) - SS | 25.4.2001 | 113,57 | 3,63 | 19,15 |
IN | Aktsiad | 703,768 M | 66 288,5 | IN Invesco | 0,4 | Tervishoiu | S&P 500 Equal Weighted / Health Care -SEC | 1.11.2006 | 30,28 | 3,04 | 19,91 |
AM | Aktsiad | 699,02 M | — | AM Amundi | 0,3 | Tervishoiu | MSCI World Index / Health Care -SEC | 19.8.2010 | 469,06 | 7,68 | 29,88 |
IS | Aktsiad | 670,635 M | 260 406,8 | IS iShares | 0,38 | Tervishoiu | DJ US Select / Health Care Providers | 1.5.2006 | 42,48 | 2,3 | 16,34 |
GX | Aktsiad | 626,554 M | — | GX Global X | 0,68 | Tervishoiu | Solactive China Biotech Index | 25.7.2019 | 72,23 | 4,18 | 30,21 |
GX | Aktsiad | 626,554 M | — | GX Global X | 0,68 | Tervishoiu | Solactive China Biotech Index | 25.7.2019 | 72,23 | 4,18 | 30,21 |
CS | Aktsiad | 615,176 M | — | CS China Southern | 0,65 | Tervishoiu | Hang Seng Biotech Index - HKD - Benchmark TR Gross | 17.6.2022 | 1,1 | 2,98 | 21,35 |
SP | Aktsiad | 604,293 M | — | SP SPDR | 0,3 | Tervishoiu | MSCI World Health Care 35/20 Capped Index - Benchmark TR Net | 29.4.2016 | 63,22 | 4,44 | 21,81 |
IS | Aktsiad | 598,291 M | — | IS iShares | 0,18 | Tervishoiu | MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped Index - Benchmark TR Net | 17.10.2019 | 7,46 | 4,16 | 22,04 |
SP | Aktsiad | 573,552 M | — | SP SPDR | 0,18 | Tervishoiu | MSCI Europe Health Care Index - EUR | 5.12.2014 | 218,89 | 3,73 | 19,22 |
SP | Aktsiad | 537,261 M | — | SP SPDR | 0,15 | Tervishoiu | S&P Health Care Select Sector Daily Capped 25/20 Index | 7.7.2015 | 45,19 | 4,86 | 22,63 |
FU | Aktsiad | 532,215 M | — | FU Fullgoal | 0,6 | Tervishoiu | CSI Pharmaceutical 50 Index - CNY - Benchmark TR Gross | 16.3.2020 | 0,94 | 0 | 0 |
GU | Aktsiad | 508,014 M | — | GU Guotai | 0,6 | Tervishoiu | CSI Shanghai-Hong Kong-Shenzhen Innovative Pharmaceutical Industry Index - CNY - Benchmark TR Gross | 8.9.2021 | 0,75 | 3,53 | 27,58 |
DI | Aktsiad | 504,181 M | 615 495,5 | DI Direxion | 0,96 | Tervishoiu | S&P Biotechnology Select Industry | 28.5.2015 | 171,39 | 0 | 0 |
IS | Aktsiad | 494,936 M | — | IS iShares | 0,66 | Tervishoiu | S&P Global 1200 Health Care Hedged to CAD Index - CAD | 12.4.2011 | 66,05 | 0 | 0 |
CH | Aktsiad | 489,926 M | — | CH ChinaAMC | 0,6 | Tervishoiu | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 23.11.2023 | 0,83 | 2,64 | 31,04 |
CS | Aktsiad | 416,909 M | — | CS China Southern | 0,2 | Tervishoiu | CSI Innovative Pharmaceutical Industrial Index - CNY - Benchmark TR Gross | 12.3.2021 | 0,65 | 3,14 | 28,61 |
IN | Aktsiad | 413,365 M | — | IN Invesco | 0,4 | Tervishoiu | NASDAQ / Biotechnology | 6.11.2014 | 59,52 | 4,94 | 21,49 |